Agile Therapeutics Reports Second Quarter 2017 Financial Results
28 juil. 2017 07h30 HE
|
Agile Therapeutics, Inc.
Cash Expected to Fund Operations into Q2 2018 FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of December 26, 2017 PRINCETON, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Agile...
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
27 juil. 2017 16h11 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that the U.S. Food and Drug Administration...
Babyscripts Raises $5.7 Million to Build the Market's Most Robust, Clinically-Validated Virtual Care Women's Health Platform
29 juin 2017 09h00 HE
|
Babyscripts
Washington, DC, June 29, 2017 (GLOBE NEWSWIRE) -- Babyscripts, the leading virtual care women's health platform, announced today that it has raised $5.7 million in new funding. Ysios Capital is the...
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®
27 juin 2017 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration...
Agile Therapeutics Announces Results of its Pre-Submission Meeting with FDA
11 avr. 2017 07h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 11, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced it has received the final meeting minutes from its recent...
CARE OF PATIENTS PRE, PERI AND POST PREGNANCY ADDRESSED DURING 37th ANNUAL ISHLT MEETING & SCIENTIFIC SESSIONS
08 avr. 2017 10h30 HE
|
International Society for Heart & Lung Transplantation
San Diego, April 08, 2017 (GLOBE NEWSWIRE) -- On the final day of the 37th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions, members...
Agile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 Conference
16 mars 2017 16h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, announced a poster presentation of data from the SECURE Phase 3 clinical...
Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
08 mars 2017 16h15 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months...
Agile Therapeutics to Present at 29th Annual ROTH Conference
01 mars 2017 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 01, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company announced today that its Chief Executive Officer, Al...
Three Finalists Named for the 2017 $100,000 Hearst Health Prize in Partnership With the Jefferson College of Population Health
24 janv. 2017 12h00 HE
|
Hearst
NEW YORK, NY and PHILADELPHIA, PA--(Marketwired - January 24, 2017) - Hearst Health, a division of Hearst, and the Jefferson College of Population Health of Thomas Jefferson University, today...